70 related articles for article (PubMed ID: 9677812)
1. [The effect of hormone substitution therapy on body weight].
Menozzi G
Minerva Ginecol; 1998 May; 50(5):213-5. PubMed ID: 9677812
[TBL] [Abstract][Full Text] [Related]
2. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
[TBL] [Abstract][Full Text] [Related]
3. Effects of postmenopausal hormone replacement therapy on body fat composition.
Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
[TBL] [Abstract][Full Text] [Related]
4. [Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].
Ortiz Núñez DA; Mengchún López G; Hernández Marín I; Mendoza R; Ayala Ruíz AR
Ginecol Obstet Mex; 2004 Jul; 72():349-55. PubMed ID: 15469174
[TBL] [Abstract][Full Text] [Related]
5. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
[TBL] [Abstract][Full Text] [Related]
6. Serum leptin concentrations in pre- and postmenopausal women on sex hormone therapy.
Bednarek-Tupikowska G; Filus A; Kuliczkowska-Płaksej J; Tupikowski K; Bohdanowicz-Pawlak A; Milewicz A
Gynecol Endocrinol; 2006 Apr; 22(4):207-12. PubMed ID: 16723307
[TBL] [Abstract][Full Text] [Related]
7. Role of ovarian hormones in the regulation of protein metabolism in women: effects of menopausal status and hormone replacement therapy.
Toth MJ; Sites CK; Matthews DE
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E639-46. PubMed ID: 16684855
[TBL] [Abstract][Full Text] [Related]
8. The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy.
Björn I; Bixo M; Nöjd KS; Collberg P; Nyberg S; Sundström-Poromaa I; Bäckström T
Gynecol Endocrinol; 2002 Feb; 16(1):1-8. PubMed ID: 11915576
[TBL] [Abstract][Full Text] [Related]
9. Effects of hormone replacement therapy on ocular function in postmenopause.
Affinito P; Di Spiezio Sardo A; Di Carlo C; Sammartino A; Tommaselli GA; Bifulco G; Loffredo A; Loffredo M; Nappi C
Menopause; 2003; 10(5):482-7. PubMed ID: 14501611
[TBL] [Abstract][Full Text] [Related]
10. Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution.
Genazzani AR; Gambacciani M
Gynecol Endocrinol; 2006 Mar; 22(3):145-50. PubMed ID: 16835076
[TBL] [Abstract][Full Text] [Related]
11. Time since menopause does not affect plasma viscosity, plasma thromboxane levels and Doppler findings.
Mancini F; Persico N; Regnani G; Volpe A; Battaglia C; de Aloysio D
Gynecol Endocrinol; 2005 Mar; 20(3):170-5. PubMed ID: 16019357
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.
Mattsson LA; Skouby S; Rees M; Heikkinen J; Kudela M; Stadnicki-Kolendo A; Mattila L; Salminen K; Vuorela A; Mustonen M;
Menopause Int; 2007 Sep; 13(3):124-31. PubMed ID: 17785038
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
Savoca S; D'Agosta S; Lombardo G
Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
[TBL] [Abstract][Full Text] [Related]
14. Effects of either tibolone or continuous combined transdermal estradiol with medroxyprogesterone acetate on coagulatory factors and lipoprotein(a) in menopause.
Perrone G; Capri O; Galoppi P; Brunelli R; Bevilacqua E; Ceci F; Ciarla MV; Strom R
Gynecol Obstet Invest; 2009; 68(1):33-9. PubMed ID: 19349712
[TBL] [Abstract][Full Text] [Related]
15. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
Sendağ F; Terek MC; Karadadaş N; Bilgin O
J Reprod Med; 2001 Nov; 46(11):962-8. PubMed ID: 11762152
[TBL] [Abstract][Full Text] [Related]
16. Serum leptin levels and body weight in postmenopausal women under transdermal hormone replacement therapy.
Salbach B; Nawroth PP; Kübler W; von Holst Th; Salbach PB
Eur J Med Res; 2000 Feb; 5(2):63-6. PubMed ID: 10720565
[TBL] [Abstract][Full Text] [Related]
17. Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
Yüksel H; Odabaşi AR; Demircan S; Karul A; Kozaci LD; Köseoğlu K; Kizilkaya K; Başak O
Gynecol Endocrinol; 2006 Jul; 22(7):381-7. PubMed ID: 16864148
[TBL] [Abstract][Full Text] [Related]
18. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
19. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
[TBL] [Abstract][Full Text] [Related]
20. Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study.
Taner MZ; Ozpolat E; Taskiran C; Onan MA; Gursel T; Karabulut E; Gursoy R; Himmetoglu O
Maturitas; 2006 Feb; 53(3):267-73. PubMed ID: 15978753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
